G1 THERAPEUTICS
Live / Registered — Registered (as of 13 Sept 2022)
What this means for you
Registered since 13 Sept 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90483777
- Registration number
- 6847725
- Mark type
- Stylized text
- Filed
- 22 Jan 2021
- Published for opposition
- 08 Mar 2022
- Registered
- 13 Sept 2022
- Attorney of record
- Shannon Marie McKeon
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for myeloprotection and anti-tumor effects; pharmaceutical preparations for reducing side effects of chemotherapy; pharmaceutical preparations for use in oncology, improving outcomes from chemotherapy, and treatment of cancer; therapeutic preparations for use in patients with cancer
- Class 042 — Scientific and technological services: Pharmaceutical research and development; providing medical and scientific research information in the fields of oncology, pharmaceuticals, therapies, diseases, and disorders
Owner
- PHARMACOSMOS HOLDING A/S, HOLB?K, DK
- G1 Therapeutics, Inc., Research Triangle Park, NC, US
- G1 Therapeutics, Inc., Research Triangle Park, NC, US
- G1 Therapeutics, Inc., Research Triangle Park, NC, US
Prosecution history
- 24 Jun 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 24 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 24 Jun 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 24 Jun 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 24 Jun 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 24 Jun 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 12 Feb 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 13 Sept 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 13 Sept 2022 — REGISTERED-PRINCIPAL REGISTER
- 06 Aug 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Aug 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 27 Jul 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Jul 2022 — USE AMENDMENT FILED
- 26 Jul 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Jul 2022 — TEAS STATEMENT OF USE RECEIVED